SCHEMBL19236511

SCHEMBL19236511

Nc1nc2c[nH]nc2c(=O)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MITF O75030 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ HBB P68871 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ QTRT1 Q9BXR0 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ PMP22 Q01453 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ PNP P00491 2/20 0.42
▸ TYMS P04818 8/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MASP2 O00187 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NUDT1 P36639 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14281548 0.77 PARP1 (0.46) ALDH1A1KDM4ELMNAGLAHSD17B10
SCHEMBL22118823 0.73 KDM4E (0.42) ALDH1A1KDM4ELMNAPMP22HSD17B10
SCHEMBL7379913 0.73 TNKS2 (0.50) TP53ALDH1A1KDM4EGLAMAPT
SCHEMBL5799688 0.70 TNKS (0.58) ALOX15ALDH1A1HSD17B10MAPTMEN1
SCHEMBL19236510 0.69 CYP1A2 (0.49) MITFTP53THRBALOX15HBB
SCHEMBL7420122 0.68 CACNA1H (0.37) ALDH1A1KDM4ELMNAPMP22HSD17B10
SCHEMBL4570270 0.67 QTRT1 (0.56) QTRT1ALDH1A1KDM4ELMNAGLA
SCHEMBL826249 0.67 TYMS (0.49) QTRT1TYMS
SCHEMBL14144916 0.67 TYMS (0.49) QTRT1TYMS
SCHEMBL7422513 0.66 ADORA3 (0.33) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017136395-A1 BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF BIOCRYST PHARMACEUTICALS, INC. (US) 2017-08-10 — — WO disclosed
Send feedback